Hypertension Clinical Trial
Official title:
Emotional Awareness and SElf-regulation for Depression in Patients With Hypertension (EASE) Study
The purpose of this study is to adapt and then evaluate the feasibility, acceptability, and
efficacy of a telephone-based intervention (UPLIFT: Using Practice and Learning to Increase
Favorable Thoughts) for individuals with elevated depressive symptoms and hypertension.
UPLIFT is a group-based intervention that is delivered over 8 weekly sessions for 1 hour/week
by phone.
Aim 1 of this study is to adapt UPLIFT using qualitative focus groups and individual
interviews and to test the adapted UPLIFT program in a single-arm design. Aim 2 of this study
is a randomized controlled trial (RCT) that will compare the effects of the adapted UPLIFT
program to usual care (UC) and to test mediators and moderators of the effects of UPLIFT.
Once 16 participants are enrolled (to form 2 groups of 8 patients each), an independent study
staff member will determine participants' group assignments. The randomization sequence will
be created a priori by Dr. Keith Goldfeld (biostatistician) by using a computer-generated
list of random numbers with stratification by antidepressant medication use and baseline
levels of depressive symptoms (PHQ scores <10 and ≥10).
UPLIFT: Eligible participants will complete 8 weekly group sessions by phone. The
intervention builds cognitive-behavioral and mindfulness skills to help reduce depressive
symptoms. Each hour-long weekly session consists of: check-in, instruction, skill building,
discussion, and a home-based practice assignment.
Usual care: Subjects randomized to UC will be advised to seek help from their primary care
physician (PCP) or other sources as they normally would if they encountered symptomatic
deterioration or other difficulties over the course of the study. All treatments received
over the course of the study for the UC group and outside of the study (for the intervention
group) will be assessed at each time point.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
| Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
| Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
| Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
| Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
| Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
| Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
| Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
| Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
| Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
| Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
| Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |